Breast Pathology Helge Stalsberg MD University Hospital of North Norway.

Slides:



Advertisements
Similar presentations
TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.
Advertisements

Pimp Session: Breast By James Lee, MD.
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Surgical Pathology of Wide Local Excision of Breast
Connie Lee, M.D. UF Surgery
Histopathology and staging of breast cancer
MCQs On Breast Imaging:
Breast Cancer Tumor Board Chair Harold Burstein, MD, PhD Faculty Jennifer Bellon, MD Mehra Golshan, MD.
Breast Alicia M. Terando, MD Assistant Professor of Surgery
Breast Dr. Raid Jastania.
Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.
Breast Pathology Dr. M. Griffin.
Breast.
AJCC TNM Staging 7th Edition Breast Case #3
Ductal Carcinoma in situ
BREAST CANCER PROF.NAZEM SHAMS. IS IT A SERIOUS PROBLEM ??
BREAST CANCER.
Breast Pathology Seminar CASE PRESENTATION PART 1 Elba Torres Matundan MD FCAP Victor Carlo Vargas MD FCAP.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Morphology of breast cancer
Breast Cancer Adapted From: SEER’s Training Web Site MCR Staff Supported by a Cooperative Agreement between.
Case Study 63: Cancer of the Female Breast
BREAST CANCER GROUP 6 :  Nuraini Ikqtiarzune Haryono( )  Tri Wahyu Ningsih ( )  Rani Yuswandaru ( )  Anita Rheza Fitriana Putri( )
Breast disease Dr. A. Basu MD.
Marion C.W. Henry, MD Yale University
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Prepared by: Hai Lam Lynn Yu Racheal Richie Trina Jones.
Breast Pathology. Breast pathology Inflammatory Disorders Acute Mastitis Preiductal Mastitis Mammary Duct Ectasia Fat Necrosis Lymphocytic Mastopathy.
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
The Breast. Acute mastitis S. aureus Breastfeeding Fever, erythema, pain Periductal mastitis – subareolar mass, smoking, keratinizing Periductal mastitis.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.
WORK UPS. Ultrasound method of choice for the differentiation of cysts from solid masses and for guidance in interventional procedures. Benign: – solid.
MAMMOGRAPHY - Pt 2 EQUIPMENT LECTURE & more….. RTEC 255 Week # 3 D. CHARMAN, M.Ed.,R.T.(R,M)
CANCER BREAST OVERVIEW Dr. Ehab M.Oraby. INTRODUCTION  Breast is a modified sweat gland between skin and pectoral fascia.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
Session 5. Case Diagnosis - Sclerosing adenosis with lobular neoplasia. No invasion in images provided.
Elsevier items and derived items © 2006 by Elsevier Inc. Assessment and Management of Patients With Breast Disorders.
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Breast Pathology Emad Raddaoui, MD, FCAP, FASC
Breast disease MUDr. Petr Šafář, CSc.. Anatomy of female breast.
Breast Diagnosis And Management of of Benign Breast Diseases Resident Basic Science Harry D. Bear, MD, PhD Division of Surgical Oncology Massey.
BREAST Begashaw M (MD). Introduction Modified sweat gland - produces milk Breast ca - most common cause of death Benign conditions  discomfort  confusion.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Interventions for Clients with Lung Cancer
The breast disease. Benign disease Present as; 1. Pain 2. Mass 3. Discharge 4. Abnormal appearance.
British/ Arab School of Pathology, June 2008 Slide Seminars.
Pathology.
Breast Cancer Dr. Gehan Mohamed. Introduction Most common female cancer. The incidence of breast cancer increases with age. 80% of cases occur in post-menopausal.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
George Cernile, Manager A.I. Technology Group Artificial Intelligence In Medicine Inc. Advancements in Automated Synoptic Reporting.
Lesions of female breast are much more common than lesions of male breast Most of these lesions are benign Breast cancer is 2 nd most common cause of.
BREASTTUMORS Ch. 18 p (704 – 713). LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR.
Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.
CA BREAST: Clinical Aspects, Investigations, Staging
Assessment and Management of Patients With Breast Disorders
Dr.Nik Makretsov, MD, PhD, FRCPC
الجامعة السورية الخاصة كلية الطب البشري قسم الجـراحـة
Dr. Sura Obay Al-Dewachi
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Current Status of Breast Ultrasound
سرطان الثدي Breast Cancer
So you have been diagnosed with breast cancer! What's next?
Treatment Overview: The Multidisciplinary Team
Handling and Evaluation of Breast Cancer Biopsy
Marion C.W. Henry, MD Yale University
(Handling and Evaluation of Breast Cancer Biopsy)
Presentation transcript:

Breast Pathology Helge Stalsberg MD University Hospital of North Norway

Major classes of breast disease Normal breast Benign breast disease Carcinoma in situ Invasive carcinoma

Normal breast Lobule and ductLobule

Benign Breast disease: Elements of fibrocystic disease Cyst Apo- crine meta- plasia Ductal hyper- plasia Sclero- sing adenosis

Benign breast disease: Fibro- adenoma Intraductal papilloma

Carcinoma in situ Ductal carcinoma in situ. DCIS Lobular carcinoma in situ. LCIS

Ductal carcinoma in situ Lobular carcinoma in situ The distribution of carcinoma in situ

Invasive carcinoma: The pathology report The definite diagnosis The local/regional extent of the disease Data relevant to prognosis Data relevant for the choice of treatment

The Pathology report, Ca. resection MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Types of invasive carcinoma Ductal Lobular TubularMucinousMedullary

Inflammatory carcinoma The diagnosis is based on clinical features: Diffuse erythema, peau d’orange, tenderness, induration, warmth, enlargement And carcinoma confirmed by biopsy: In most cases an invasive ductal carcinoma grade 3 with tumor in dermal lymphatics

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE (1-3): 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Tumor grading FeatureScore Tubule formation1-3 Nuclear atypia1-3 Number of mitoses1-3 GradeSum of scores Grade 13-5 Grade 26-7 Grade 38-9

Tumor grades Grade 1Grade 3

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Orientation of the specimen

Inking of resection margins

The inked surface as seen in the microscopic slide

Examination of resection margin Section 2 Section 1 Inked margin Skin

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Tumor tissue Lymph vessel Vascular invasion

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE (1-3): 3 DCIS MINIMUM DISTANCE TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Axillary lymph nodes Breast cancer spreads through lymphatic channels to axillary lymph nodes. When axillary content is removed, all nodes are searched and embedded for microscopy

Micrometastasis Micrometastasis spotted in otherwise negative sentinel node

Tumor deposits in lymph node SizeDesignatedpTNM class > 2 mmMetastasispN1 ≤ 2 mm; > 0.2 mmMicrometastasispN1(mi) ≤ 0.2 mmIsolated tumor cellspN0 (i+)

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Immunohistochemistry: Estrogen receptor Negative: No benefit from hormone therapy Positive: Will benefit from hormone therapy

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Immunohistochemistry Her-2 Her-2 positive. Will benefit from Herceptin therapy

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

The Pathology report MAIN DIAGNOSIS: Local resection (lumpectomy) of breast with invasive ductal carcinoma OTHER FEATURES: TUMOR SIZE: 3 cm LOCATION: Upper inner quadrant, right breast TUMOR GRADE: 2 RESECTION MARGINS, MINIMUM DISTANCE TO TUMOR: 4 mm from dorsal margin, 32 mm from ventral margin TUMOR INVASION OF SKIN, MUSCLE, PAGET’S DISEASE OF THE NIPPLE: Absent. VASCULAR INVASION: Present DCIS: Present DCIS GRADE: 3 DCIS MIN. DIST. TO RESECTION MARGIN: 1 mm to dorsal margin NO. OF LYMPH NODES EXAMINED: 13 NO. OF LYMPH NODES WITH TUMOR: 5 HORMONE RECEPTOR STATUS: Positive for estrogen receptor Negative for progesteron receptor Her-2 STATUS: Negative (2+ by immunohistochemistry, negative by FISH) pTNM CLASSIFICATION: pT1N2Mx EXTRA-TUMORAL BREAST: Fibrocystic disease

Is Breast pathology in Ghana similar to that in the industralized countries ? A comparison of non-inflammatory pathology diagnoses in Ghana (KATH) and Norway (UNN)

The relative frequency of major pathology diagnoses in breast specimens from KATH and UNN DiagnosisGhana, KATH (162) Norway, UNN (2173) N%N% Fibroadenoma4628 %31114 % Fibrocystic dis.2012 %52424 % Atypical hyperpl00 %281 % Carcinoma in situ64 %30114 % Carcinoma9056 % %

The relative frequency of main types of invasive breast carcinoma TypeGhana, KATH (92) Norway, UNN (1012) N%N% Ductal and NOS8592,487386,3 Lobular11,1979,6 Tubular00,0101,0 Mucinous33,3252,5 Medullary11,130,3 Papillary22,230,3

Tumor grade in Core biopsies of Breast cancer Preliminary data 2009 Tumor gradeGhana (25 cases) Norway (93 cases) Grade 116%33% Grade 228%44% Grade 348%16% E. Adjei

Hormone receptors in Core biopsies of Breast cancer Preliminary data 2009 Hormone receptor Ghana (25 cases) Norway (93 cases) Estrogen receptor 48% positive89% positive Progesteron receptor 12% positive62% positive E. Adjei

Her-2 overexpression in Core biopsies of Breast cancer Preliminary data 2009 Ghana (25 cases) Norway (93 cases) 32% positive12% positive E.Adjei